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Engagement of the immunoreceptors initiates signaling cas-
cades resulting in lymphocyte activation and differentiation 
to effector cells, which are essential for the elimination of 
pathogens from the body. For the transduction of these im-
munoreceptor-mediated signals, several linker proteins term-
ed transmembrane adaptor proteins (TRAPs) were shown to 
be required. TRAPs serve as platforms for the assembly and 
membrane targeting of the specific signaling proteins. Amo-
ng seven TRAPs identified so far, LAT and LIME were shown 
to act as a positive regulator in TCR-mediated signaling 
pathways. In this review, we will discuss the functions of LAT 
and LIME in modulating T cell development, activation and 
differentiation. 
[Immune Network 2009;9(2):53-57]
INTRODUCTION
Lymphocytes  respond  to  various  extracellular  stimuli  medi-
ated by surface molecules such as immunoreceptors (e.g., the 
T cell receptors; TCR, the B cell receptors; BCR, or the Fc 
receptors; FcR) and additional coreceptors (e.g., CD28 for T 
cells  and  CD19  for  B  cells).  As  the  earliest  immunor-
eceptor-mediated  biochemical  events,  Src-family  protein  ty-
rosine kinases (PTKs) become activated. In turn, activated Src 
PTKs  phosphorylate  immunoreceptor  tyrosine-based  activa-
tion motifs (ITAMs) within the cytoplasmic tails of immunor-
eceptor-associated signaling molecules (e.g., CD3 complexes 
i n  T  c e l l s  a n d  I g α a n d  I g β  in  B  cells).  Subsequently, 
Syk-family PTKs are recruited through their SH2 domains and 
activated  by  phosphorylation  by  Src-family  PTKs  (1).  Once 
activated,  Syk  family  PTKs  in  combination  with  Src-family 
PTKs phosphorylate a variety of downstream effector mole-
cules,  including  transmembrane  adaptor  proteins  (TRAPs). 
TRAPs  contain  up  to  10  tyrosine-based  signaling  motifs 
(TBSM) in the cytoplasmic region. Upon antigen receptor en-
gagement,  these  tyrosine  sites  are  phosphorylated  by  Src- 
and/or Syk-family PTKs and serve as the binding motifs for 
signaling  molecules  possessing  either  SH2  or  phosphotyr-
osine-binding  (PTB)  domains.  In  this  manner,  TRAPs  serve 
as  platforms  to  enhance  signaling  efficiency  by  assembling 
and concentrating signaling components to the plasma mem-
brane  proximal  sites.
    The transmembrane adaptor protein family includes seven 
members named LAT (The linker for activation of T cells) (2), 
LIME (Lck-interacting transmembrane adaptor protein) (3,4), 
LAX  (linker  for  activation  if  X  cells)  (5),  NTAL/LAB  (non 
T-cell  activation  liner/linker  fir  activation  of  B  cells)  (6), 
PAG/Cbp  (phosphoprotein  associated  with  glycosphingoli-
pid-enriched domain/Csk-binding protein) (7), SIT (SHP2-in-
teracting TRAP) (8), and TRIM (TCR-interacting molecule) (9). 
TRAPs have common structural features by possessing a short 
extracellular domain, a single transmembrane domain, and a 
long cytoplasmic region with several potential tyrosine phos-
phorylation sites. In the juxtamembrane portion of their cyto-
plasmic region, LAT, LIME, NTAL/LAB, and PAG/Cbp possess 
d i c y s t e i n  m o t i f  C X X C  ( C ;  C y s t e i n ,  X ;  a n y  a m i n o  a c i d )  t h a t  
serves as palmitoylation sites. Palmitoylation of this motif al-
lows the targeting of the transmembrane adaptor proteins to 
lipid rafts, a specialized region of plasma membrane enriched 
with other signaling molecules, such as Src-family PTKs (10). 
On the other hand, LAX, SIT and TRIM, which lack palmitoy-Transmembrane Adaptor Proteins Positively Regulating the Activation of Lymphocytes
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Table I. Characteristics of TRAPs
Protein size
Name TBSM CXXC motif Expression Binding partners
modification
 Raft-
 associated
LAT 213-234 aa
36-38 kDa
9C
26XXC
29 T cell, pre-B cell, NK cell, 
mast cell, platelet
Grb2, Gads, PI3K, PLCγ, 
Grap, 3BP2, Shb
LIME 268 aa
31 kDa
Dimerization
5C
28XXC
31 T cell, B cell Lck, Fyn, Csk, Pi3K, SHP2,
Grb2
NTAL 219 aa
30 kDa
8C
25XXC
28 B cell, NK cell, mast cell,
macrophage, activated T cell
Grb2
PAG 396 aa
68-85 kDa
9C
37XXC
40 Ubiquitous Fyn, Csk, EBP50
 Non-raft 
 associated
LAX 328 aa
70 kDa
8 - T cell, B cell, mast cell Grb2, Gads, PI3K
SIT 159 aa
30-40 kDa (monomer)
N-glycosylation
Disulfide-linked 
Dimerization (C
26)
  5/10 - T cell, B cell Grb2, SHP2
TRIM 136 aa
30 kDa (monomer)
Disulfide-linked 
Dimerization (C
7)
3/6 - T cell CD3γ/δ/ε,
TCRγ, PI3K
lation sites, are mainly localized in non-raft region and seem 
to  be  involved  in  signaling  cascades  in  different  cellular 
compartments. In spite of their similar structural features, the 
functions  of  TRAPs  are  relatively  specialized  depending  on 
their  expression  patterns  and  binding  partners  (Table  I).
    Through the previous studies using cell lines and primary 
immune  cells  isolated  from  genetically  engineered  mice, 
TRAPs  were  shown  to  integrate  immunoreceptor-mediated 
signals in either positive or negative manner. Particularly in 
this review, we will focus on LAT and LIME, which exert pos-
itive regulatory functions in T lymphocytes. For the readers 
of this review, the characteristics of each TRAPs are summar-
ized  in  Table  I.
LINKER FOR ACTIVATION OF T CELLS (LAT)
LAT was initially identified as a phosphoprotein which is rap-
idly phosphorylated following TCR ligation (2). The expres-
sion of LAT is limited to thymic and peripheral T cells, NK 
cells,  mast  cells,  megakaryocytes,  platelet,  and  bone-mar-
row-derived pre-B cells, but not mature B cells and mono-
cytes (2). LAT possesses nine TBSMs in cytoplasmic tail, and 
becomes  phosphorylated  at  least  five  tyrosine  residues  by 
ZAP-70 or Syk kinases upon immunoreceptor engagement. In 
addition, LAT is phosphorylated by Itk upon CD28 engage-
ment  (11).  After  phosphorylation,  LAT  recruits  Grb2,  Gads, 
Grap, PLCγ1, p85 PI3K, Vav, 3BP2, and Shb directly via their 
SH2-domain,  and  mediates  activation  of  Ras/MAPK,  intra-
cellular  calcium  influx,  and  cytoskeleton  reorganization 
(12,13).  Four  distal  tyrosines  primarily  responsible  for  LAT 
function are Y132 for PLCγ1, Y171 for PI3K, Y171 and Y191 
for Gads, Y191 and Y226 for Vav, Y171, Y191, and Y226 for 
Grb2, respectively (13). Through the constitutive interaction 
with Gads, SLP-76 is recruited to LAT upon TCR engagement 
and in turn, serves as a platform for several signaling mole-
cules such as Vav, NCK, ITK and ADAP. The LAT-SLP-76-PLC
γ1 complex formation is required for phosphorylation of PLC
γ1,  allowing  optimal  calcium  mobilization  following  TCR 
ligation. On the other hand, the recruitment of Vav, NCK and 
A D A P  t h r o u g h  S L P - 7 6  s e e m s  t o  p r o p a g a t e  a c t i n  p o l y m e r -
ization and integrin activation. In addition, the recruitment of 
Grb2  is  essential  in  the  activation  of  Ras/MAPK  signaling 
pathway  (Fig.  1).
    In LAT-deficient Jurkat T cell line, optimal tyrosine phos-
phorylation of PLCγ1, Vav, and SLP-76 are impaired, result-
ing in the diminished TCR-mediated calcium mobilization and Transmembrane Adaptor Proteins Positively Regulating the Activation of Lymphocytes
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Figure 1. Signaling pathways mediated by LAT. Upon TCR engage-
ment, Src-family kinase, Lck, is activated and phosphorylates the 
tyrosine residues within ITAM motifs on CD3γ/ε/ζ  chains. 
Subsequently, Syk-family kinase, ZAP-70, is recruited through its SH2
domain and become activated by phosphorylation by Lck. Activated 
ZAP-70 phosphorylates the tyrosine residues within TBSMs of 
raft-associated LAT, allowing the recruitment of other signaling 
molecules possessing SH2 domains or phosphotyrosine-binding (PTB)
domains including Gads, Grb2, PLCγ1 at the membrane proximal 
sites. Through the constitutive interaction with Gads, SLP-76 are 
recruited to LAT and become phosphorylated by ZAP-70. The 
recruitment of Itk via SLP-76 is required for full activation of PLCγ 1. 
Activated PLCγ1 hydrolyze the phosphatidylinositol 4, 5 bisphos-
phate (PIP2) to inositol 3, 4, 5-triohosphate (IP3) and diacylglycerol 
(DAG), leading to the calcium mobilization and NF-κB activation. 
Tyrosine-phosphorylated SLP-76 also provides docking sites for Vav, 
Nck and ADAP, forming signaling complexes for actin reorganization.
Together with Grb2/Sos-mediated Ras/MAPK activation, these signal-
ing pathways cooperatively activate the IL-2 poduction and T cell 
proliferation. These positive signaling pathways can be negatively 
regulated by the inhibition of Lck activity by PAG-associated Csk 
kinase.
MAPK  activation  (14,15).  When  SLP-76  is  targeted  con-
stitutively to plasma membrane in LAT-deficient Jurkat T cells, 
the signaling defects are restored, suggesting that major signal 
transduction  downstream  of  LAT  is  mediated  by  SLP-76  re-
cruited  to  lipid  rafts  (16).
    Through the extensive studies using genetically engineered 
mice, it was revealed that LAT is critical in thymocyte devel-
opment as well as mature T cell activation. In LAT-deficient 
mice, B cells NK cells, and platelets appear to develop nor-
m a l l y ,  b u t  c r u c i a l  d e f e c t s  a r e  f o u n d  i n  t h y m o c y t e  d e v e l o p-
ment at double-negative stage, resulting in lack of mature pe-
ripheral T cell population (17). This suggests that LAT is es-
sential for the pre-TCR signal transduction. Moreover, func-
tional restoration studies using the LAT knock-in mice harbor-
ing  individual  mutations  of  these  tyrosine  residues  support 
the importance of LAT in T cell functions. Similar to LAT-defi-
cient mice, mutant mice with point mutations in all distal four 
tyrosine  residues  have  defects  in  thymocyte  development 
(18). LAT Y132F mice which possess a mutation in PLCγ1 
binding site also have partial defects in thymocyte develop-
ment  in  DN  stage  (19,20).  Unexpectedly,  however,  Y132F 
mice develop autoimmune phenotype with augmented Th2- 
type cytokines and B cell proliferation. These results suggest 
that  LAT  may  also  function  as  a  negative  modulator  in 
lymphocytes.
    As previously indicated, LAT is palmitoylated at two cystein 
residues, Cys
26 and Cys
29, near the transmembrane domain in 
cytoplasmic  region,  and  palmitoylated  LAT  is  targeted  con-
stitutively to lipid rafts. Inhibition of palmitoylation on these 
c y s t e i n  r e s i d u e s  a b r o g a t e s  l i p i d  r a f t  t a r g e t i n g  o f  L A T  ( 1 2 ) .  
However, it seems that LAT localization to lipid rafts is not 
essential  during  normal  T  cell  activation  and  development. 
The reconstitution of LAT-deficient cell line with the LAX-LAT 
chimeric protein consisting of the cytoplasmic region of LAT 
fused with the transmembrane region of non-raft TRAP, LAX 
restored MAPK activation, calcium flux, and NFAT activation 
in LAT-deficient cells (21). Furthermore, the defects in thymo-
cyte development and peripheral T cell responses in LAT-de-
ficient  mice  are  rescued  by  the  reconstitution  with  the  chi-
meric LAX-LAT protein (21). Therefore, it seems that the lo-
calization to lipid rafts may not directly affect the function of 
LAT in normal T cell activation and development. On the oth-
er hand, the raft localization of LAT may differentially affect 
its function in anergic T cells. It has been recently shown that 
palmitoylation of LAT is defective in anergic T cells (22). The 
early  TCR  signaling  events  such  as  CD3ξ-chain  phosphor-
ylation  or  Zap-70  phosphorylation  are  intact  in  these  cells, 
however, tyrosine phosphorylation of LAT and calcium mobi-
lization  by  PLCγ1  activation  are  significantly  diminished. 
Interestingly,  the  palmitoylation  defect  in  anergic  T  cells  is 
likely  specific  to  LAT,  yet  the  mechanism  is  still  unclear. 
LCK-INTERACTING TRANSMEMBRANE ADAPTOR 
PROTEIN (LIME)
Another raft-associated TRAP, LIME was identified as a pos-
itive regulator of immunoreceptor signaling (3,4). Originally, 
LIME was identified as a binding partner of Lck by yeast two 
hybrid screening (3). In Jurkat T cells, unlike LAT or NTAL, 
which are phosphorylated by Syk-family PTKs, LIME interact 
with  and  is  phosphorylated  by  Lck  upon  TCR  stimulation. Transmembrane Adaptor Proteins Positively Regulating the Activation of Lymphocytes
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Subsequently, LIME recruits the cytoplasmic proteins such as 
Lck, Fyn, Vav, p85 PI3K, Grb2, Gads, Shp-2, and Csk (3,4) 
to  membrane  proximal  sites.  In  addition,  LIME  was  shown 
to  be  phosphorylated  by  cross-linking  of  CD4  or  CD8  cor-
eceptors (4). LIME also possesses a dicystein palmitoylation 
motif  and  localize  in  the  lipid  rafts.
    The binding partners of LIME are, in part, common with 
those  of  LAT,  which  include  Gads,  p85  PI3K,  and  Grb2 
(3,13,14). When ectopically overexpressed in Jurkat T cells, 
LIME promotes TCR-mediated signaling pathways to drive cal-
cium mobilization, MAPK activation, and IL-2 production (3). 
In  contrast  to  the cell  line  studies,  however,  LIME-deficient 
mice show no significant alteration in the development of thy-
mocytes,  peripheral  T  cells,  as  well  as  other  immune  cells 
such as B cells, mast cells, and macrophages (Unpublished 
data, ref (23)). In addition, TCR-mediated responses such as 
T  cell  proliferation  and  cytokine  production  are  normal  in 
LIME-deficient mice, suggesting that LIME is dispensible in the 
development and activation of naïve T cells. The reason for 
the  discrepancy  between  the  results  from  cell  line  and 
knock-out mice studies is not clear at this stage. Unlike LAT, 
LIME expression is barely detectable in thymocytes and rest-
ing T cells but largely upregulated upon T cell activation (3). 
Thus,  it  is  likely  that  LAT  acts  as  a  main  signal  transducer 
of pre-TCR and TCR signaling for the development of thymo-
cytes and the activation of naïve peripheral T cells, whereas 
LIME may function in the later stage of T cell activation. It 
will be interesting to test whether the function of LIME is re-
dundant  to  that  of  LAT  in  activated/effector  T  cells.
  LIME is also expressed in B cells. In B cell lines, after its 
phosphorylation  by  Lyn,  LIME  augments  BCR-mediated  sig-
naling  pathways  leading  to  activation  of  NFAT  and  NF-κ B 
pathways  (24).  However,  the  experiments  using  LIME-defi-
cient mice show that LIME is dispensable in the development 
and  the  function  of  B  cells  (23).  Furthermore,  the  absence 
of LIME has no further effect on the autoimmune syndrome 
of NTAL-deficient mice (23). Interestingly, histological analy-
sis reveals that LIME is expressed in plasma cells, as well as 
myeloma/plasmacytoma (25). Further studies are required to 
elucidate  the  functions  of  LIME  especially  in  the  effector  T 
cells  or  plasma  B  cells.
CONCLUSION
So far, both LAT and LIME were found to positively regulate 
TCR-mediated  signaling  events.  However,  unlike  LAT-defi-
cient mice, LIME-deficient mice are normal in the thymocyte 
development and peripheral T cell activation. Although the 
binding partners are partially overlapping, LAT and LIME also 
have several distinct characteristics. First, LAT is phosphory-
lated by Syk-family kinases, while LIME is phosphorylated by 
Lck.  Second,  the  expression  patterns  of  LAT  and  LIME  are 
different.  LAT  is  expressed  starting  from  double  negative 
s t a g e  o f  t h y m o c y t e s  a n d ,  i n  p e r i p h e r a l  T  c e l l s ,  t h e  l e v e l  i s 
constant  regardless  of  the  activation  status.  On  the  other 
hand, LIME expression is barely detectable in thymocytes and 
resting peripheral T cells and upregulated upon T cell activa-
tion and differentiation to effector T cells. In addition, LIME 
but not LAT is also expressed in B cells. Therefore, it is ex-
pected  that  the  biological  function  of  LAT  and  LIME  are 
different. As LIME is induciblely expressed upon TCR engage-
ment,  it  will  be  interesting  to  study  the  physiological  sig-
n i f i c a n c e  o f  L I M E  i n  e f f e c t o r / m e m o r y  T  c e l l s .
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